Archives

VANCOUVER -- Protox Therapeutics Inc. (TSX-V:PRX) today announced positive final results from its Phase 1 clinical trial evaluating PRX302 in patients with localized, recurrent prostate cancer following radiation failure. The trial results, an extension of those released on July 10, 2007, indicate that PRX302 is well tolerated and shows promising signs of therapeutic activity. "In addition to demonstrating that PRX302 was well tolerated, early signs of therapeutic activity seen at this stage are promising," said Dr.

BOSTON -- Most experts agree that supplements add little, if anything, to a well-balanced diet. Exercise, however, is proven to achieve the benefits claimed for vitamins, even for people who eat properly, reports the November 2007 issue of Harvard Men's Health Watch. One leading reason people take vitamin supplements is to protect against cancer. But sadly, this strategy has been a flop. While studies continue on whether vitamin E and selenium can help reduce prostate cancer risk, data already show that beta carotene actually boosts the risk of lung cancer in smokers.

The ability to fight off cancer is passed from parent to child in their genes, research shows. The life-giving inheritance emerged in a study of the health of millions of families. It showed that children whose parents live for at least ten years after being diagnosed with breast, prostate, bowel or lung cancer are more likely to survive the disease themselves. Unfortunately, this also means that children of those who have lost their battle against cancer are more likely to die if they develop the same form of the disease.

WASHINGTON -- For the third year in a row, the federal government received failing grades in Lung Cancer Alliance's (LCA) Annual 2007 Report Card, issued today to mark the start of Lung Cancer Awareness Month.

LOS ANGELES -- A novel mechanism to predict survival in older women with early stage lung cancer has been uncovered by researchers at UCLA's Jonsson Comprehensive Cancer Center, a discovery that may have significant implications for new treatment approaches. For the first time, UCLA researchers linked higher levels of aromatase, an enzyme that naturally makes estrogen from another hormone called androgen, to more aggressive disease and lower survival rates in women over 65 with Stage I or II lung cancer.

VANCOUVER -- Perceptronix Medical Inc. (Perceptronix) announced today the completion of their clinical study entitled "Spectral Imaging of Early Lung Cancer and Pre-cancerous Lesions" using the Company's ClearVu Elite(TM) system. Perceptronix is a laboratory service and medical device company focused on the development and commercialization of effective technologies that can improve the early detection, localization, diagnosis and follow-up of cancer. The Company's initial focus is lung cancer.

The ability to fight off cancer is passed from parent to child in their genes, research shows. The life-giving inheritance emerged in a study of the health of millions of families. It showed that children whose parents live for at least ten years after being diagnosed with breast, prostate, bowel or lung cancer are more likely to survive the disease themselves. Unfortunately, this also means that children of those who have lost their battle against cancer are more likely to die if they develop the same form of the disease.

WASHINGTON -- American Legacy Foundation(R) Campaign Code Blue for Lung Cancer Focuses on Nation's Number-One Cancer Killer A national public service campaign, Code Blue for Lung Cancer, says that the nation's number-one cancer killer might not be what you think. Lung cancer is the leading cancer killer in America. Earlier this year, The American Legacy Foundation released a research study stating that two-thirds of women inaccurately believed breast cancer to be the leading cause of cancer death among women.

WASHINGTON -- Researchers at the Virginia Commonwealth University have identified the enzyme sphingosine kinase 2 (SphK2) as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer. In the Nov. 1 issue of the journal Cancer Research, researchers examined human colon and breast cancer cells and established a role of SphK2, an enzyme that has an important influence in the death of cancer cells mediated by the chemotherapeutic drug, doxorubicin.

NUTLEY, N.J. -- Maximizing on the momentum gained during Breast Cancer Awareness Month, healthcare providers and advocacy organizations now have a helpful resource to offer cancer patients -- OralChemoAdvisor.com -- an educational, state-of-the-art Web site about oral chemotherapy. This straightforward, credible site is designed to help cancer patients and their family members make more informed healthcare decisions concerning oral chemotherapy treatment.